Literature DB >> 11314773

Skin function and skin disorders in Parkinson's disease.

M Fischer1, I Gemende, W C Marsch, P A Fischer.   

Abstract

Cutaneous symptoms (seborrhoea and hyperhidrosis) in Parkinson's disease were investigated. In 70 treated patients with Parkinson's disease and 22 control subjects, non-invasive bioengineering methods (sebumetry, corneometry, pH) were carried out on the forehead, sternum and forearm. In addition, concomitant dermatoses and medication were recorded. 18.6% of the patients had seborrhoea on the forehead (>220 microg/cm2), 51.4% showed normal sebum values (100-220 microg/cm2) and 30% a sebostasis (<100 microg/cm2). Males has significantly higher sebum values than females. No relationship between the seborrhoea and the therapy for Morbus Parkinson was found. Patients with hyperhidrosis (n = 36) had significantly lower pH values (p < 0.05) on the forehead than those without hyperhidrosis. 22 patients (31.9%) reported a cold/hot flush and a further 13 (18.8%) had clinical rosacea. Seborrhoea is rare in treated Parkinsonian patients but hyperhidrosis is frequently found. Furthermore, a particular lack of vasostability (flush) appears to be an autonomic dysregulation in the skin related to Morbus Parkinson, which has not been studied to any extent to date.

Entities:  

Mesh:

Year:  2001        PMID: 11314773     DOI: 10.1007/s007020170088

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  16 in total

1.  Sebum production and fractional 17-ketosteroid excretion in parkinsonism.

Authors:  P E POCHI; J S STRAUSS; H MESCON
Journal:  J Invest Dermatol       Date:  1962-01       Impact factor: 8.551

2.  Sebum secretion in idiopathic Parkinson's disease: effect of anticholinergic and dopaminergic drugs.

Authors:  J C Villares; E A Carlini
Journal:  Acta Neurol Scand       Date:  1989-07       Impact factor: 3.209

3.  Sebum-excretion rate and skin-surface lipid composition in Parkinson's disease before and during therapy with levodopa.

Authors:  J A Cotterill; W J Cunliffe; B Williamson; W A Arrowsmith; J B Cook; D Sumner
Journal:  Lancet       Date:  1971-06-19       Impact factor: 79.321

4.  Effect of L-dopa on seborrhoea of parkinsonism.

Authors:  J L Burton; S Shuster
Journal:  Lancet       Date:  1970-07-04       Impact factor: 79.321

Review 5.  Measurement of skin pH.

Authors:  S Dikstein; A Zlotogorski
Journal:  Acta Derm Venereol Suppl (Stockh)       Date:  1994

6.  Alpha 2-adrenergic mechanism in menopausal hot flushes.

Authors:  R R Freedman; S Woodward; S C Sabharwal
Journal:  Obstet Gynecol       Date:  1990-10       Impact factor: 7.661

7.  Is seborrhea a sign of autonomic impairment in Parkinson's disease?

Authors:  E Martignoni; L Godi; C Pacchetti; E Berardesca; G P Vignoli; G Albani; F Mancini; G Nappi
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

8.  Clinical, ultrasound and hormonal markers of androgenicity in acne vulgaris.

Authors:  S Walton; W J Cunliffe; K Keczkes; A S Early; H H McGarrigle; M Katz; R A Reese
Journal:  Br J Dermatol       Date:  1995-08       Impact factor: 9.302

9.  Sweat function in Parkinson's disease.

Authors:  Y Mano; T Nakamuro; T Takayanagi; R F Mayer
Journal:  J Neurol       Date:  1994-10       Impact factor: 4.849

10.  Acne is not associated with abnormal plasma androgens.

Authors:  M J Levell; M L Cawood; B Burke; W J Cunliffe
Journal:  Br J Dermatol       Date:  1989-05       Impact factor: 9.302

View more
  11 in total

Review 1.  Practical management of psoriasis in the elderly: epidemiology, clinical aspects, quality of life, patient education and treatment options.

Authors:  Gil Yosipovitch; Mark B Y Tang
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 2.  Sweating dysfunctions in Parkinson's disease.

Authors:  Masaaki Hirayama
Journal:  J Neurol       Date:  2006-12       Impact factor: 4.849

Review 3.  Dopaminergic Therapies for Non-motor Symptoms in Parkinson's Disease.

Authors:  Eva Schaeffer; Daniela Berg
Journal:  CNS Drugs       Date:  2017-07       Impact factor: 5.749

4.  Skin conditions in early Parkinson's disease.

Authors:  Deepika Dinesh; Jong Soo Lee; Xiang Gao; Natalia Palacios
Journal:  Parkinsonism Relat Disord       Date:  2021-01-29       Impact factor: 4.891

5.  Cognitive impairments in Parkinson's disease: Evidence from an Iranian population.

Authors:  Farzad Ashrafi; Alireza Zali; Hossein Pakdaman; Karim Johari
Journal:  Iran J Neurol       Date:  2012

Review 6.  Skin disorders in Parkinson's disease: potential biomarkers and risk factors.

Authors:  Astrid-Helene Ravn; Jacob P Thyssen; Alexander Egeberg
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-03-09

Review 7.  Updates on the Risk of Neuropsychiatric and Gastrointestinal Comorbidities in Rosacea and Its Possible Relationship with the Gut-Brain-Skin Axis.

Authors:  Yu Ri Woo; Yu Jin Han; Hei Sung Kim; Sang Hyun Cho; Jeong Deuk Lee
Journal:  Int J Mol Sci       Date:  2020-11-10       Impact factor: 5.923

8.  Prevention and Treatment of Hardware-Related Infections in Deep Brain Stimulation Surgeries: A Retrospective and Historical Controlled Study.

Authors:  Jiping Li; Wenjie Zhang; Shanshan Mei; Liang Qiao; Yunpeng Wang; Xiaohua Zhang; Jianyu Li; Yongsheng Hu; Xiaofei Jia; Yuqing Zhang
Journal:  Front Hum Neurosci       Date:  2021-08-26       Impact factor: 3.169

Review 9.  The Skin and Parkinson's Disease: Review of Clinical, Diagnostic, and Therapeutic Issues.

Authors:  Matej Skorvanek; Kailash P Bhatia
Journal:  Mov Disord Clin Pract       Date:  2016-09-08

10.  Assessment of Tachykinin Receptor 3' Gene Polymorphism rs3733631 in Rosacea.

Authors:  Anthony Karpouzis; Paschalis Avgeridis; Gregory Tripsianis; Elisavet Gatzidou; Niki Kourmouli; Stavroula Veletza
Journal:  Int Sch Res Notices       Date:  2015-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.